Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors

Medical and Pediatric Oncology

Volumn 36, Issue 4, 2001, Pages 434-441

  Kebudi, Rejin ^a   Görgün, Ömer ^a   Ayan, Nci ^a   Gürler, Nezahat ^b   Akici, Ferhan ^a   Töreci, Kurtulu ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cefepime; Ceftazidime; Childhood cancer; Febrile neutropenia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; GLYCOPEPTIDE; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LYMPHOMA; MALE; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT; SOLID TUMOR; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; CANDIDIASIS; CEFTAZIDIME; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; MALE; NEOPLASMS; NEUTROPENIA; STATISTICS, NONPARAMETRIC;

EID: 0035082071     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1107     Document Type: Article

References (35)

1. Management of the cancer patient with fever and prolonged neutropenia
2. Granulocytopenia and cancer therapy
3. Approaching the controversies in the anti-bacterial management of cancer patients
4. Infectious complications in the paediatric cancer patient
5. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia
6. Monotherapy for fever and neutropenia in cancer patients: A randomized comparison of ceftazidime versus imipenem
7. Ceftazidime compared with piperacilin and tobramycin for the empiric treatment of fever and neutropenic patients with cancer
8. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients
9. Cefoperazone for the treatment of infections in patients with cancer
10. A randomized comparison of cefoperazone/sulbactam versus ceftazidime in febrile neutropenic patients with solid tumours
11. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients
12. Open randomized study of cefepime vs. Piperacilin-gentamisin for treatment of febrile neutropenic cancer patients
13. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
14. Cefepime the next generation?
15. In vitro activity of cefepime and other antimicrobials: Survey of European isolates
16. Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients
17. Ambulatory treatment with ceftriaxone in febrile neutropenic children
18. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial
19. Ceftazidime and colony stimulating factors in febrile neutropenia
20. Cefepime versus ceftazidime as empiric treatment of febrile episodes in neutropenic patients
21. Piperacillin/tazobactam vs. Cefepime as an initial empiric antimicrobial therapy in febrile neutropenic patients: A prospective randomized pilot study
22. Cefepime/Amikacin versus Ceftazidime/Amikacin as empirical therapy for febrile episodes in neutropenic patients: A comparative study
23. Cefepime versus ceftazidime in the empiric treatment of febrile neutropenic children with malignancy
24. Cefepim and ceftazidime in combination with amikasin in febrile neutropenia of childhood: Which regimen is more effective?
25. Therapy of infections in cancer patients
26. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from the EORTC studies
27. A randomized comparison of cefoperazone/sulbactam versus ceftazidime in febrile neutropenic patients with solid tumors
28. American Society of Clinical Oncology recommendations for the use of haematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
29. Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumours treated with ifosfamide, carboplatin and etoposide chemotherapy
30. Randomized, placebo-controlled trial of filgastrim in patients with febrile neutropenia following chemotherapy
31. rh GM-CSF in the treatment of fever and neutropenia. A double-blind, placebo-controlled study in children with malignancy
32. G-CSF significantly reduces the nadir of neutropenia, hospitalizations and costs during intensive chemotherapy in children with solid tumours